nach oben

Erschienen in:

02.01.2018 | Oncology

¹⁸F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients

verfasst von: Kirsten M. Selnæs, Brage Krüger-Stokke, Mattijs Elschot, Frode Willoch, Øystein Størkersen, Elise Sandsmark, Siver A. Moestue, May-Britt Tessem, Dag Halvorsen, Eirik Kjøbli, Anders Angelsen, Sverre Langørgen, Helena Bertilsson, Tone F. Bathen

Erschienen in: European Radiology | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the diagnostic potential of simultaneous ¹⁸F-fluciclovine PET/MRI for pelvic lymph node (LN) staging in patients with high-risk prostate cancer.

Methods

High-risk prostate cancer patients (n=28) underwent simultaneous ¹⁸F-fluciclovine PET/MRI prior to surgery. LNs were removed according to a predefined template of eight regions. PET and MR images were evaluated for presence of LN metastases according to these regions. Sensitivity/specificity for detection of LN metastases were calculated on patient and region basis. Sizes of LN metastases in regions with positive and negative imaging findings were compared with linear mixed models. Clinical parameters of PET-positive and -negative stage N1 patients were compared with the Mann-Whitney U test.

Results

Patient- and region-based sensitivity/specificity for detection of pelvic LN metastases was 40 %/87.5 % and 35 %/95.7 %, respectively, for MRI and 40 %/100 % and 30 %/100 %, respectively, for PET. LN metastases in true-positive regions were significantly larger than metastases in false-negative regions. PET-positive stage N1 patients had higher metastatic burden than PET-negative N1 patients.

Conclusion

Simultaneous ¹⁸F-fluciclovine PET/MRI provides high specificity but low sensitivity for detection of LN metastases in high-risk prostate cancer patients. ¹⁸F-Fluciclovine PET/MRI scan positive for LN metastases indicates higher metastatic burden than negative scan.

Key Points

• ¹⁸F-Fluciclovine PET/MRI has high specificity for detection of lymph node metastasis.

• ¹⁸F-Fluciclovine PET/MRI lacks sensitivity to replace ePLND.

• ¹⁸F-Fluciclovine PET/MRI may be used to aid surgery and select adjuvant therapy.

• ¹⁸F-Fluciclovine PET-positive patients have more extensive disease than PET-negative patients.

• Size of metastatic lymph nodes is an important factor for detection.

Nur mit Berechtigung zugänglich

Hovels AM, Heesakkers RA, Adang EM et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387–395CrossRefPubMed

Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137CrossRefPubMed

Briganti A, Chun FK, Salonia A et al (2006) Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50:1006–1013CrossRefPubMed

Sankineni S, Brown AM, Fascelli M et al (2015) Lymph node staging in prostate cancer. Curr Urol Rep 16:30CrossRefPubMedPubMedCentral

Schuster DM, Nieh PT, Jani AB et al (2014) Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. J Urol 191:1446–1453CrossRefPubMed

Turkbey B, Mena E, Shih J et al (2014) Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis. Radiology 270:849–856CrossRefPubMed

Poulsen MH, Bouchelouche K, Hoilund-Carlsen PF et al (2012) [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients. BJU Int 110:1666–1671CrossRefPubMed

Beheshti M, Imamovic L, Broinger G et al (2010) 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. Radiology 254:925–933CrossRefPubMed

Maurer T, Gschwend JE, Rauscher I et al (2016) Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. J Urol 195:1436–1443CrossRefPubMed

10.

Odewole OA, Tade FI, Nieh PT et al (2016) Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT. Eur J Nucl Med Mol Imaging 43:1773–1783CrossRefPubMedPubMedCentral

11.

Nanni C, Zanoni L, Pultrone C et al (2016) (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial. Eur J Nucl Med Mol Imaging 43:1601–1610CrossRefPubMed

12.

Oka S, Okudaira H, Yoshida Y, Schuster DM, Goodman MM, Shirakami Y (2012) Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol 39:109–119CrossRefPubMed

13.

Okudaira H, Nakanishi T, Oka S et al (2013) Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. Nucl Med Biol 40:670–675CrossRefPubMed

14.

Sorensen J, Owenius R, Lax M, Johansson S (2013) Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer. Eur J Nucl Med Mol Imaging 40:394–402CrossRefPubMed

15.

Elschot M, Selnaes KM, Sandsmark E et al (2017) A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer. Eur J Nucl Med Mol Imaging 44:695–703CrossRefPubMed

16.

(2016) FDA Approves 18F-Fluciclovine and 68Ga-DOTATATE Products. J Nucl Med 57:9N

17.

Schuster DM, Votaw JR, Nieh PT et al (2007) Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. J Nucl Med 48:56–63PubMed

18.

Suzuki H, Inoue Y, Fujimoto H et al (2016) Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial. Jpn J Clin Oncol 46:152–162CrossRefPubMed

19.

Inoue Y, Asano Y, Satoh T et al (2014) Phase IIa Clinical Trial of Trans-1-Amino-3-(18)F-Fluoro-Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer. Asia Ocean J Nucl Med Biol 2:87–94PubMedPubMedCentral

20.

D'Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974CrossRefPubMed

21.

Joniau S, Van den Bergh L, Lerut E et al (2013) Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 63:450–458CrossRefPubMed

22.

Cardillo G (2006) Clinical test performance: the performance of a clinical test based on the Bayes theorem

23.

Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945CrossRefPubMed

24.

Axumin (fluciclovine F 18) Injection, Printed Labeling Available via https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208054Orig1s000Lbl.pdf

25.

Lyons K, Seghers V, Sorensen JI et al (2015) Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol 205:1094–1101CrossRefPubMed

26.

Schiavina R, Scattoni V, Castellucci P et al (2008) 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 54:392–401CrossRefPubMed

27.

Steuber T, Schlomm T, Heinzer H et al (2010) [F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study. Eur J Cancer 46:449–455CrossRefPubMed

28.

van Leeuwen PJ, Emmett L, Ho B et al (2017) Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer. BJU Int 119:209–215CrossRefPubMed

29.

Reyes DK, Pienta KJ (2015) The biology and treatment of oligometastatic cancer. Oncotarget 6:8491–8524CrossRefPubMedPubMedCentral

30.

Engel J, Bastian PJ, Baur H et al (2010) Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol 57:754–761CrossRefPubMed

31.

Gakis G, Boorjian SA, Briganti A et al (2014) The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur Urol 66:191–199CrossRefPubMed

32.

Delso G, Furst S, Jakoby B et al (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922CrossRefPubMed

33.

Briganti A, Karnes JR, Da Pozzo LF et al (2009) Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 55:261–270CrossRefPubMed

Titel: 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients
verfasst von: Kirsten M. Selnæs
Brage Krüger-Stokke
Mattijs Elschot
Frode Willoch
Øystein Størkersen
Elise Sandsmark
Siver A. Moestue
May-Britt Tessem
Dag Halvorsen
Eirik Kjøbli
Anders Angelsen
Sverre Langørgen
Helena Bertilsson
Tone F. Bathen
Publikationsdatum: 02.01.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 8/2018
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-017-5213-1

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

¹⁸F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients

Abstract

Objective

Methods

Results

Conclusion

Key Points

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Key Points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2018

The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI

Monitoring cerebral blood flow change through use of arterial spin labelling in acute ischaemic stroke patients after intra-arterial thrombectomy

Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling

From radiation osteitis to osteoradionecrosis: incidence and MR morphology of radiation-induced sacral pathologies following pelvic radiotherapy

Comparison of image quality and radiation dose between split-filter dual-energy images and single-energy images in single-source abdominal CT

Correction to: A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie